Companies Reconsider Selling Ex-US Rights Due To MFN Drug Pricing Policy

Lower Pricing In Other Countries Would Impact US Prices

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.